Morningstar's Phoenix Life Sciences International Ltd Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Phoenix Life Sciences International Ltd's Company Profile
Phoenix Life Sciences International Ltd is an adaptive healthcare solutions company. Its business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. The company strive to create partnerships and integrate these programs for human health into communities worldwide as part of its Global Health Initiative. Its products include Onco, Metabolic, Transdermal Patche, Medi-Strip Relaxation, and others.
Las Vegas, NV, 89139